Benzodiazepine Discontinuation
Conditions
Interventions
Intervention: Gamified acceptance &
commitment therapy for benzodiazepine discontinuation Period: 5 weeks
Intervention: Psychoeducation program Period: 5 weeks
Sponsors
Nagoya City University Graduate School of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Regular use: 5 times a week and over Required use: 4 times a week and less Use for infomnia: Before sleeping 2.Being prescrived benzodiazepine regulary 12 weeks and over. 3.Being prescribed benzodiazepine once a day and over.(Excluded only for required use or use for insomnia) 4.Willing to stop using benzodiazepine and treating physician determine eligibility to stop benzodiazepine. 5.Being able to access the program and having an Email address for daily use. 6. Having no plan to be hospitalized more than 1 week for any reason. 7.Having no plan to transfer to a different hospital within 4 months. 8.Being able to respond to assessments via telephone. 9.Being able to understand and sign a written informed consent.
Exclusion criteria
Exclusion criteria: 1.Being regulary prescribed 3 types of benzodiazepine and over. (excluded required use or use for insomnia) 2.Actively satisfied diagnostic cliteria with Mini-International Neuropsychiatric Interview. 3.Being regularly prescribed antipsychotic or mood stabilizer (lithium, valproate, carbamazepine and lamotrigine) 4.Imminent risk of suicide as judged by the treating physician. 5.Currently participating in another clinical intervention study. 6. Family members living with the researchers of the present study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate of benzodiazepine discontinuation during the 11th and 12th week after beginning of the program | — |
Secondary
| Measure | Time frame |
|---|---|
| Benzodiazepine reduction rate,Recovery Assessment Scale(RAS),Depression Anxiety Stress Scale(DASS),Severity of Dependence syndrome(SDS),Euro Qol 5 Dimension(EQ5-D),Cognitive Fusion Questionnaire(CFQ),Personal Values Questionnaire II (PVQ-II) | — |
Countries
Japan
Contacts
Public ContactToshitaka ii
Nagoya City University Graduate School of Medical Sciences Department of Psychiatry,
Outcome results
None listed